Delivery Order SPE2DB25D3008-SPE2DB25FRBDY
Award Date
1/29/25
Potential Completion Date
1/30/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GARDASIL 9 vaccine syringes, a pharmaceutical product used to prevent certain types of human papillomavirus (HPV) infections. The contract has a ceiling value of $20,339.98 and is a firm fixed-price contract with an ultimate completion date of September 19, 2024. Amerisourcebergen, a major...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of Gardasil 9 syringes, a vaccine for the prevention of certain types of human papillomavirus (HPV). The $34,423.12 firm-fixed-price contract has a completion date of June 25, 2024. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,324.13 Firm Fixed Price Delivery Order is for the supply of Gardasil 9 syringes, a vaccine for the prevention of certain types of human papillomavirus. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the supply of GARDASIL 9 vaccine syringes, a 0.5 ML single-dose human papillomavirus vaccine. The delivery order has a ceiling value of $7,734.36 and a completion date of October 17, 2024. No set-aside requirements were specified for this contract. Amerisourcebergen, a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of GARDASIL 9 syringes, a vaccine product, valued at $11,523.25. The delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $8,902.47 firm-fixed-price contract is for the delivery of GARDASIL 9 syringes, a human papillomavirus vaccine, to support military healthcare programs. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 syringes. The firm-fixed-price contract has a ceiling value of $10,074.63 and is set to expire on July 31, 2024. Amerisourcebergen will be providing the GARDASIL 9 vaccine syringes, which are used to deliver the immunization against certain types of human papillomavirus. This contract is not designated as a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,565.62 firm fixed-price contract is for the delivery of Gardasil 9 vaccine syringes. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,088.01, is for the delivery of GARDASIL 9 syringes (0.5mL) with a completion date of November 18, 2024. The contract is a delivery order under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,124.75, is for the supply of GARDASIL 9 syringes, a vaccine product. The contract has a firm fixed-price pricing structure and a completion date of November 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...